Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MDT · against 26 other Healthcare companies of similar size
Ranked #23 of 27 · scores higher than 15% of peers
Bars: peers in each 10-point band of the valuation score5 peers with a valuation score of 50–59, including MDT · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | MDT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 26 reported | 4.1% | 4.1% | 52% | 30% | |
| EBITDA yieldHigher is better · 27 reported | 7.1% | 7.1% | 50% | 50% | |
| Free cash flow yieldHigher is better · 24 reported | 4.8% | 5.1% | 48% | 20% | |
| Book yieldHigher is better · 25 reported | 39.7% | 22.3% | 67% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 177.5B USD | 92 | 71 | |
| 2 | 78.1B USD | 89 | 60 | |
| 3 | 108.6B USD | 88 | 66 | |
| 4 | 97.5B USD | 87 | 67 | |
| 5 | 126.1B USD | 83 | 62 | |
| 19 | 119.1B USD | 59 | 57 | |
| 20 | 189.3B USD | 57 | 45 | |
| 21 | 134.5B USD | 55 | 70 | |
| 22 | 161.8B USD | 53 | 50 | |
| 23 | 126.5B USD | 50 | 56 | |
| 24 | 155.7B USD | 47 | 64 | |
| 25 | 66.3B USD | 44 | 30 | |
| 26 | 207.7B USD | 8 | 18 | |
| 26 | 91.2B USD | 8 | 18 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score